Leerink Partnrs Equities Analysts Raise Earnings Estimates for Immunovant, Inc. (NASDAQ:IMVT)
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Equities researchers at Leerink Partnrs lifted their FY2024 EPS estimates for Immunovant in a research report issued on Monday, February 12th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings of ($1.63) per share for the year, up from their prior forecast of ($1.69). […]
More Stories
‘I saw the blood on the tarmac’: top UN official in Yemen recounts aftermath of Israel airstrike on civilian airport
Fresh details of the Israeli airstrike on Sana’a airport, which occurred as Tedros Ghebreyesus, the Director-General of the World Health...
Quest PharmaTech (CVE:QPT) Trading 40% Higher – Should You Buy?
Quest PharmaTech Inc. (CVE:QPT – Get Free Report) shares shot up 40% on Friday . The stock traded as high...
Short Interest in Siemens Energy AG (OTCMKTS:SMEGF) Drops By 64.5%
Siemens Energy AG (OTCMKTS:SMEGF – Get Free Report) was the target of a large drop in short interest in the...
Positron Co. (OTCMKTS:POSC) Short Interest Down 66.7% in December
Positron Co. (OTCMKTS:POSC – Get Free Report) was the recipient of a significant drop in short interest during the month...
Kraft Heinz Target of Unusually Large Options Trading (NASDAQ:KHC)
The Kraft Heinz Company (NASDAQ:KHC – Get Free Report) was the recipient of unusually large options trading activity on Friday....
Triumph Gold (CVE:TIG) Trading 35.3% Higher – Still a Buy?
Triumph Gold Corp. (CVE:TIG – Get Free Report)’s stock price traded up 35.3% during mid-day trading on Friday . The...